TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Valeritas Holdings, Inc. (NASDAQ:VLRX) Investor Investigation Announced

  • If you purchased shares of Valeritas Holdings, Inc. (NASDAQ:VLRX) and currently hold any of those NASDAQ:VLRX shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Valeritas Holdings, Inc.
Security
NASDAQ: VLRX

Summary

August 10, 2017 (Shareholders Foundation) - An investigation on behalf of investors in shares of Valeritas Holdings, Inc. (NASDAQ:VLRX) was announced over potential breaches of fiduciary duties by certain officers and directors at Valeritas Holdings.

The investigation by a law firm concerns whether certain Valeritas Holdings directors breached their fiduciary duties and caused damage to the company and its shareholders.

Bridgewater, NJ based Valeritas Holdings, Inc. is a commercial-stage medical technology company. The Company is focused on developing technologies for Type 2 diabetes. Valeritas Holdings, Inc. reported that its annual Total Revenue rose from $18.10 million in 2015 to $19.55 million in 2016 and that its Net loss declined from $67.19 million in 2015 to $46.37 million in 2016.

Shares of Valeritas Holdings, Inc. (NASDAQ:VLRX) closed on August 10, 2017 at $5.64 per share.

Start Monitoring Your Investments